OTCMKTS:OPTHF Optimi Health (OPTHF) Stock Price, News & Analysis → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free OPTHF Stock Alerts $0.30 -0.02 (-5.94%) (As of 06/7/2024 08:53 PM ET) Add Compare Share Share Today's Range$0.30▼$0.3250-Day Range$0.18▼$0.3652-Week Range$0.11▼$0.43Volume3,900 shsAverage Volume15,900 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Optimi Health alerts: Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Optimi Health Stock (OTCMKTS:OPTHF)Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.Read More OPTHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPTHF Stock News HeadlinesJune 3, 2024 | prnewswire.comOptimi Health Awarded Drug Establishment Licence From Health CanadaMay 31, 2024 | prnewswire.comOptimi Health Announces Closing of Fully Subscribed $1,500,000 FinancingMay 29, 2024 | finance.yahoo.comOptimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin CapsulesMay 22, 2024 | globenewswire.comOptimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive DisorderMay 15, 2024 | proactiveinvestors.comOptimi Health secures certification for 40mg and 60mg MDMA GMP capsulesMay 14, 2024 | finance.yahoo.comOptimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP CapsulesMay 10, 2024 | finanznachrichten.deOptimi Health Corp.: Optimi Health Provides Corporate UpdateMay 10, 2024 | globenewswire.comOptimi Health Provides Corporate UpdateMay 9, 2024 | finance.yahoo.comOptimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic ResearchApril 23, 2024 | globenewswire.comOptimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and ResearchApril 15, 2024 | finance.yahoo.comOptimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)April 11, 2024 | uk.investing.comOptimi Health Signs Psilocybin Supply Agreement With New Zealand-Based MÄ tai Medical Research InstituteApril 9, 2024 | benzinga.comOptimi To Supply Psilocybin For New Zealand's Mātai Medical Research InstituteApril 9, 2024 | globenewswire.comOptimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research InstituteApril 4, 2024 | finance.yahoo.comEarly Warning Press Release in Accordance with National Instrument 62-103April 2, 2024 | globenewswire.comOptimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin ExtractMarch 28, 2024 | globenewswire.comOptimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development ConferenceMarch 26, 2024 | msn.comTwo Top Biotechs Forge MDMA Supply Deals For An Expanding Research FieldMarch 26, 2024 | globenewswire.comOptimi Health to Supply MDMA for Psychedelic Research at Tel Aviv UniversityMarch 18, 2024 | ca.finance.yahoo.comOil prices build on last week's gains as supply risks riseFebruary 28, 2024 | globenewswire.comOptimi Announces Closing of First Tranche of Non-Brokered Private PlacementFebruary 18, 2024 | finance.yahoo.comOptimi Health Corp. (OPTHF)February 12, 2024 | finance.yahoo.comOptimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production VideoFebruary 8, 2024 | finance.yahoo.comOptimi Announces Non-Brokered Private PlacementFebruary 6, 2024 | finance.yahoo.comOptimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And PractitionersSee More Headlines Receive OPTHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:OPTHF CUSIPN/A CIKN/A Webwww.optimihealth.ca Phone778-761-4551FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. John James Wilson (Age 34)Co-Founder & Non-Executive Chairman Comp: $79.69kMr. William J. Ciprick (Age 47)Chief Executive Officer Comp: $257.05kMr. Bryan Edward Safarik (Age 39)Co-Founder, COO & Director Comp: $96.39kMr. Jacob Safarik (Age 37)Co-Founder, CFO & Director Comp: $99.33kMr. Dane Stevens (Age 34)Co-Founder, Chief Marketing Officer & Director Comp: $58.02kDr. Preston A. ChaseChief Science OfficerLaura ChowDirector of Products & SalesMs. Ann LittleHuman Resources ManagerMs. Leah Hodges (Age 40)Corporate Secretary More ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors OPTHF Stock Analysis - Frequently Asked Questions How have OPTHF shares performed in 2024? Optimi Health's stock was trading at $0.1865 at the beginning of the year. Since then, OPTHF stock has increased by 61.4% and is now trading at $0.3010. View the best growth stocks for 2024 here. Are investors shorting Optimi Health? Optimi Health saw a increase in short interest in May. As of May 15th, there was short interest totaling 24,200 shares, an increase of 591.4% from the April 30th total of 3,500 shares. Based on an average trading volume of 33,800 shares, the days-to-cover ratio is presently 0.7 days. View Optimi Health's Short Interest. How do I buy shares of Optimi Health? Shares of OPTHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OPTHF) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Optimi Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.